Clinical Trials Directory

Trials / Completed

CompletedNCT00759330

Flurbiprofen Tape for Treatment of Chronic Low Back Pain

A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial of Flurbiprofen Tape for Treatment of Chronic Low Back Pain

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
127 (actual)
Sponsor
Teikoku Pharma USA, Inc. · Industry
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this trial is to evaluate the analgesic efficacy and safety of flurbiprofen tape for chronic low back pain (lasting greater than 3 months).

Detailed description

This study is a multi-center, randomized, double-blind, placebo-controlled study in patients with daily low back pain below the 12th thoracic vertebra of greater than 3 months duration. Patients also had an average daily pain score of 4 or greater on an 11-point categorical pain scale for the last 3 days of the baseline phase. The study began with a 14-day washout period of previously used pain medications. At the end of the 14-day baseline phase, patients were randomized to 1 of 4 treatments: Flurbiprofen tape applied once daily for 12 hours, Flurbiprofen tape applied once daily for 24 hours, placebo tape applied once daily for 12 hours, or placebo tape applied once daily for 24 hours. During the 7-day treatment phase, patients applied 2 treatment tapes once daily for 7 days. The tapes remained on for 12 or 24 hours of continuous treatment, depending on the treatment to which they were randomized. Patients were provided with rescue medication. After 7 days of tape treatment, patients returned to the clinic for a study exit visit.

Conditions

Interventions

TypeNameDescription
DRUGPlacebo Tape (Arm 1)Two placebo tapes (one on each side of the spine) were applied on the lower back area once daily for 7 days.
DRUGFlurbiprofen Tape (Arm 2)Two flurbiprofen tapes (one on each side of the spine) were applied on the lower back area once daily for 7 days. Each tape contained 31.5 mg flurbiprofen for a total daily dose of 63 mg.
DRUGPlacebo Tape (Arm 3)Two placebo tapes (one on each side of the spine) were applied on the lower back area once daily for 7 days.
DRUGFlurbiprofen Tape (Arm 4)Two flurbiprofen tapes (one on each side of the spine) were applied on the lower back area once daily for 7 days. Each tape contained 31.5 mg flurbiprofen for a total daily dose of 63 mg.

Timeline

Start date
2007-10-01
Primary completion
2008-07-01
Completion
2008-07-01
First posted
2008-09-25
Last updated
2016-10-06
Results posted
2016-10-06

Locations

10 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00759330. Inclusion in this directory is not an endorsement.

Flurbiprofen Tape for Treatment of Chronic Low Back Pain (NCT00759330) · Clinical Trials Directory